Asghar Ali

Dr. Asghar Ali

Biochemistry, Jamia Hamdard, New Delhi, India
orcid
Young Scientist

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
Asghar AliAsghar Ali
Asghar Ali
Khalid I. AlHussainiKhalid I. AlHussaini
Khalid I. AlHussaini
Helicobacter pylori (H. pylori) is a Gram-negative bacterium that colonizes the gastric mucosa and is associated with various gastrointestinal disorders. H. pylori is a pervasive pathogen, infecting nearly 50% of the world’s population, and presents a substantial concern due to its link with gastric cancer, ranking as the third most common cause of global cancer-related mortality. This review article provides an updated and comprehensive overview of the current understanding of H. pylori infection, focusing on its pathogenesis, diagnosis, and treatment strategies. The intricate mechanisms underlying its pathogenesis, including the virulence factors and host interactions, are discussed in detail. The diagnostic methods, ranging from the traditional techniques to the advanced molecular approaches, are explored, highlighting their strengths and limitations. The evolving landscape of treatment strategies, including antibiotic regimens and emerging therapeutic approaches, is thoroughly examined. Through a critical synthesis of the recent research findings, this article offers valuable insights into the contemporary knowledge of Helicobacter pylori infection, guiding both clinicians and researchers toward effective management and future directions in combating this global health challenge.

2 January 2025 in Life
Verified
Journal Article
Open access
PDF file
KAKASHISH AZEEM
KASHISH AZEEM
SFSadaf Fatima
Sadaf Fatima
Asghar AliAsghar Ali
Asghar Ali
AUAyesha Ubaid
Ayesha Ubaid
FHFohad Mabood Husain
Fohad Mabood Husain
MAMOHAMMAD ABID
MOHAMMAD ABID
Biofilms, composed of structured communities of bacteria embedded in a self-produced extracellular matrix, pose a significant challenge due to their heightened resistance to antibiotics and immune responses. This review highlights the mechanisms underpinning antibiotic resistance within bacterial biofilms, elucidating the adaptive strategies employed by microorganisms to withstand conventional antimicrobial agents. This encompasses the role of the extracellular matrix, altered gene expression, and the formation of persister cells, contributing to the recalcitrance of biofilms to eradication. A comprehensive understanding of these resistance mechanisms provides a for exploring innovative therapeutic interventions. This study explores promising avenues for future research, emphasizing the necessity of uncovering the specific genetic and phenotypic adaptations occurring within biofilms. The identification of vulnerabilities in biofilm architecture and the elucidation of key biofilm-specific targets emerge as crucial focal points for the development of targeted therapeutic strategies. In addressing the limitations of traditional antibiotics, this review discusses innovative therapeutic approaches. Nanomaterials with inherent antimicrobial properties, quorum-sensing inhibitors disrupting bacterial communication, and bacteriophages as biofilm-specific viral agents are highlighted as potential alternatives. The exploration of combination therapies, involving antimicrobial agents, biofilm-disrupting enzymes, and immunomodulators, is emphasized to enhance the efficacy of existing treatments and overcome biofilm resilience.

29 July 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
Asghar AliAsghar Ali
Asghar Ali
AZAndaleeb Zahra
Andaleeb Zahra
MKMohan Kamthan
Mohan Kamthan
FHFohad Mabood Husain
Fohad Mabood Husain
TAThamer Albalawi
Thamer Albalawi
MNMd Salik Noorani
Md Salik Noorani
Biofilms are complex communities of microorganisms that grow on surfaces and are embedded in a matrix of extracellular polymeric substances. These are prevalent in various natural and man-made environments, ranging from industrial settings to medical devices, where they can have both positive and negative impacts. This review explores the diverse applications of microbial biofilms, their clinical consequences, and alternative therapies targeting these resilient structures. We have discussed beneficial applications of microbial biofilms, including their role in wastewater treatment, bioremediation, food industries, agriculture, and biotechnology. Additionally, we have highlighted the mechanisms of biofilm formation and clinical consequences of biofilms in the context of human health. We have also focused on the association of biofilms with antibiotic resistance, chronic infections, and medical device-related infections. To overcome these challenges, alternative therapeutic strategies are explored. The review examines the potential of various antimicrobial agents, such as antimicrobial peptides, quorum-sensing inhibitors, phytoextracts, and nanoparticles, in targeting biofilms. Furthermore, we highlight the future directions for research in this area and the potential of phytotherapy for the prevention and treatment of biofilm-related infections in clinical settings.

27 January 2020 in ACS Sustainable Chemistry & Engineering
Verified
Journal Article
Closed access
LRLuqman Jameel Rather
Luqman Jameel Rather
QZQi Zhou
Qi Zhou
Asghar AliAsghar Ali
Asghar Ali
QHQazi Mohd. Rizwanul Haque
Qazi Mohd. Rizwanul Haque
QLQing Li
Qing Li

1 May 2020 in Dyes and Pigments
Verified
Journal Article
Closed access
QZQi Zhou
Qi Zhou
LRLuqman Jameel Rather
Luqman Jameel Rather
Asghar AliAsghar Ali
Asghar Ali
WWWuchao Wang
Wuchao Wang
YZYanyun Zhang
Yanyun Zhang
QLQing Li
Qing Li

4 March 2021 in ACS Food Science & Technology
Verified
Journal Article
Closed access
LRLuqman Jameel Rather
Luqman Jameel Rather
QZQi Zhou
Qi Zhou
Asghar AliAsghar Ali
Asghar Ali
QHQazi Mohd. Rizwanul Haque
Qazi Mohd. Rizwanul Haque
QLQing Li
Qing Li